Author

Silvia Bordel-Vozmediano

University of Castilla-La ManchaORCID 0009-0008-5521-4993Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:imaging· 1 Approach:mechanistic / dynamical model· 1

Frequent Co-Authors

Gabriel F. CalvoiD· 1 shared José García OteroiD· 1 shared Matteo ItaliaiD· 1 shared Víctor M. Pérez‐GarcíaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Gabriel F. CalvoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintDec 19, 2025

Radiopharmaceutical therapy for metastatic prostate cancer: Insights from mechanistic modeling and in silico trials

Matteo Italia, Silvia Bordel-Vozmediano, José García Otero…·Víctor M. Pérez‐García

This paper develops a mechanistic model to simulate [177Lu]Lu-PSMA RPT in mCRPC, using virtual patients to optimize dosing schedules and evaluate efficacy-toxicity trade-offs.

DOI 10.64898/2025.12.17.694859

humanimaging

𝕏 PostBluesky